Evidence map›Paper›PMID 38266090›Full record

ArticleScience advances2024

Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium.

Nicholas Strash, Sophia DeLuca, Geovanni L Janer Carattini, Yifan Chen, Tianyu Wu, Abbigail Helfer, Jacob Scherba, Isabella Wang, Mehul Jain, Ramona Naseri and 1 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Nicholas StrashDepartment of Cell Biology, Duke University, Durham NC, USA.ORCID 0000-0003-1907-0925
Sophia DeLucaDepartment of Cell Biology, Duke University, Durham NC, USA.ORCID 0000-0001-9432-8186
Geovanni L Janer CarattiniDepartment of Biomedical Engineering, Duke University, Durham NC, USA.ORCID 0000-0002-8149-8001
Yifan ChenDepartment of Biomedical Engineering, Duke University, Durham NC, USA.ORCID 0009-0004-9858-6077
Tianyu WuDepartment of Biomedical Engineering, Duke University, Durham NC, USA.ORCID 0000-0002-7341-2781
Abbigail HelferDepartment of Biomedical Engineering, Duke University, Durham NC, USA.ORCID 0000-0002-8981-5024
Jacob ScherbaDepartment of Biomedical Engineering, Duke University, Durham NC, USA.ORCID 0000-0001-8187-0507
Isabella WangDepartment of Biomedical Engineering, Duke University, Durham NC, USA.
Mehul JainDepartment of Biomedical Engineering, Duke University, Durham NC, USA.
Ramona NaseriDepartment of Biomedical Engineering, Duke University, Durham NC, USA.
Nenad BursacDepartment of Cell Biology, Duke University, Durham NC, USA.ORCID 0000-0002-5688-6061
Duke University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Training Program in Developmental & Stem Cell BiologyT32HD040372 · NICHD · DUKE UNIVERSITY · PI Terry H Lechler · 2001 to 2026
$8.9M
Integrated Cellular and Tissue Engineering for Ischemic Heart DiseaseU01HL134764 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BURSAC, NENAD, KAMP, TIMOTHY J. · 2016 to 2022
$7.7M
Engineering Human Heart Tissues with Polyploid CardiomyocytesR01HL164013 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2022 to 2025
$2.2M
Investigating the Role of Polyploidy in the Maturation of hiPSC-derived CardiomyocytesF31HL156453 · NHLBI · DUKE UNIVERSITY · PI STRASH, NICHOLAS A · 2021 to 2023
$105k
Investigating Mitogenic Mechanism and Therapeutic Efficacy of Adenosine Deaminase Knockout in Human and Murine CardiomyocytesF31HL162460 · NHLBI · DUKE UNIVERSITY · PI DELUCA, SOPHIA BUNNELL · 2022 to 2023
$84k
NHLBI NIH HHS F31 HL156453NHLBI NIH HHS F31 HL162460NHLBI NIH HHS R01 HL164013NHLBI NIH HHS U01 HL134764NICHD NIH HHS T32 HD040372NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

Candidate cardiomyocyte (CM) mitogens such as those affecting the extracellular signal-regulated kinase (ERK) signaling pathway represent potential targets for functional heart regeneration. We explored whether activating ERK via a constitutively active mutant of B-raf proto-oncogene (BRAF),

Indexed as

MyocardiumProto-Oncogene Proteins B-rafAnimalsExtracellular Signal-Regulated MAP KinasesMyocytes, CardiacRatsSignal TransductionExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins B-raf

Identifiers

PMID38266090
PMCPMC10807800
OpenAlexW4391205602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.